LANDOS BIOPHARMA INC
COM NEW · CUSIP 515069201
0
institutional holders
-16 vs Q1 2024
—reported value*
0 new
0 added
0 reduced
16 sold out
net sold ≈ $34.9m (-1.6m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q2 2023 | 9 |
| Q3 2023 | 12 |
| Q4 2023 | 10 |
| Q1 2024 | 16 |
| Q2 2024 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2023 | 4 | 1 |
| Q4 2023 | 4 | 2 |
| Q1 2024 | 9 | 1 |
| Q2 2024 | 0 | 16 |
Biggest buyers
| None |
Biggest sellers
| PERCEPTIVE ADVISORS LLC | Sold out | -1.5m |
| DELTEC ASSET MANAGEMENT LLC | Sold out | -50.0k |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -18.9k |
| MACQUARIE GROUP LTD | Sold out | -14.7k |
| Virtu Financial LLC | Sold out | -14.5k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -12.6k |
| Black Maple Capital Management LP | Sold out | -10.4k |
| PenderFund Capital Management Ltd. | Sold out | -9.3k |
| UBS Group AG | Sold out | -4.1k |
| Tower Research Capital LLC (TRC) | Sold out | -896 |
Holders, Q2 2024
| Manager | Shares | Change |
|---|